CN Patent

CN112755014A — 双氯芬酸制剂和使用方法

Assigned to APR Applied Pharma Research SA · Expires 2021-05-07 · 5y expired

What this patent protects

本发明涉及双氯芬酸制剂和使用方法。提供使用双氯芬酸和双氯芬酸制剂治疗偏头痛和其它急性痛发作的方法和制剂，该双氯芬酸制剂提供对急性痛的快速和持续缓解。也提供治疗偏头痛和急性痛的伴随症状例如畏光、恐响、恶心和呕吐的方法和制剂。

USPTO Abstract

本发明涉及双氯芬酸制剂和使用方法。提供使用双氯芬酸和双氯芬酸制剂治疗偏头痛和其它急性痛发作的方法和制剂，该双氯芬酸制剂提供对急性痛的快速和持续缓解。也提供治疗偏头痛和急性痛的伴随症状例如畏光、恐响、恶心和呕吐的方法和制剂。

Drugs covered by this patent

diclofenac-potassium (DICLOFENAC POTASSIUM)

Patent Metadata

Patent number: CN112755014A
Jurisdiction: CN
Classification: —
Expires: 2021-05-07
Drug substance claim: No
Drug product claim: No
Assignee: APR Applied Pharma Research SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.